Talan David A, Moran Gregory J, Abrahamian Fredrick M
David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Infect Dis Clin North Am. 2008 Mar;22(1):1-31, v. doi: 10.1016/j.idc.2007.09.005.
Increased attention has focused recently on the acute management of severe sepsis and septic shock, conditions that represent the end-stage systemic deterioration of overwhelming infection. Clinical trials have identified new therapies and management approaches that, when applied early, appear to reduce mortality. Practice guidelines have been advanced by critical care societies, and many of the proposed interventions involve therapies other than antimicrobials directed at hemodynamic resuscitation or addressing adverse effects of the inflammatory cascade. Although many emergency departments (EDs) are now adopting treatment protocols for sepsis that are based on published treatment guidelines, recent research calls many of the initial recommendations into question, and validation trials of some of these approaches are ongoing. This article reviews the initial evaluation and treatment considerations of sepsis in the ED setting.
近来,人们越来越关注严重脓毒症和脓毒性休克的急性处理,这两种病症是严重感染导致的终末期全身功能恶化状态。临床试验已确定了一些新的治疗方法和管理策略,早期应用时似乎可降低死亡率。重症监护学会已提出了实践指南,许多建议的干预措施涉及除抗菌药物之外的其他治疗方法,旨在进行血流动力学复苏或应对炎症级联反应的不良反应。尽管现在许多急诊科正在采用基于已发表治疗指南的脓毒症治疗方案,但近期研究对许多初始建议提出了质疑,其中一些方法的验证试验正在进行中。本文综述了急诊科环境中脓毒症的初始评估和治疗注意事项。